Skip to content

Construction of a Database for TMA

Construction of a Database for Thrombotic Microangiopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05634928
Enrollment
500
Registered
2022-12-02
Start date
2022-12-01
Completion date
2028-11-30
Last updated
2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombotic Microangiopathies

Brief summary

Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.

Interventions

collection data

Sponsors

The First Affiliated Hospital of Soochow University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL

Inclusion criteria

* The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis.

Exclusion criteria

* The investigator considers the subject unable or unwilling to cooperate with the study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with stroke5 years from the time of entering the database.Stroke was assessed with MRI imaging.

Countries

China

Contacts

Primary ContactYue Han, PhD
hanyue@suda.edu.cn+86 18913091817

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026